会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Array and method for dosing a hormone regulating blood sugar in a patient
    • 用于给予调节患者血糖的激素的阵列和方法
    • US07806853B2
    • 2010-10-05
    • US12471150
    • 2009-05-22
    • Uwe WittmannHelmut RinneRalf GesslerHans-Joerg Pfleiderer
    • Uwe WittmannHelmut RinneRalf GesslerHans-Joerg Pfleiderer
    • A61M31/00
    • A61M5/1723A61B5/14532A61M5/14244A61M2230/201A61M2230/62G06F19/00
    • The invention concerns an array and a method for dosing a hormone regulating the blood glucose, especially insulin, of a diabetic patient. In order to improve the administration of the hormone, the invention provides the following characteristic combination: a first sensor for measuring tissue glucose level; a controller having as an input the measured tissue glucose level from the first sensor, the controller having a control algorithm to determine an amount of hormone to be dosed based upon the measured tissue glucose level; a hormone dosing unit connected to the controller and automatically administering a hormone dose based upon a signal received from the controller; a second sensor for measuring an influencing patient variable; a pilot control device connected to the second sensor, the pilot control device connected to and forming a circuit with the controller, the pilot control device acting on the controller in accordance with the influencing patient variable that is measured by the second sensor, whereby the pilot control device reduces dead time of the controller.
    • 本发明涉及用于给予调节糖尿病患者的血糖,特别是胰岛素的激素的阵列和方法。 为了改善激素的施用,本发明提供以下特征组合:用于测量组织葡萄糖水平的第一传感器; 控制器具有来自第一传感器的测量的组织葡萄糖水平作为输入,控制器具有控制算法,用于基于所测量的组织葡萄糖水平来确定要给药的激素的量; 激素计量单元,其连接到所述控制器并基于从所述控制器接收的信号自动施用激素剂量; 用于测量影响患者变量的第二传感器; 连接到所述第二传感器的先导控制装置,所述先导控制装置与所述控制器连接并与所述控制器形成电路,所述先导控制装置根据由所述第二传感器测量的影响的患者变量作用在所述控制器上, 控制装置减少控制器的死区时间。
    • 4. 发明授权
    • Device for determining a glucose concentration in a tissue fluid
    • 用于测定组织液中葡萄糖浓度的装置
    • US07169600B2
    • 2007-01-30
    • US10782290
    • 2004-02-19
    • Udo HossHans-Joerg PfleidererRalf GesslerHans-Ulrich ZietenRolf Fussgaenger
    • Udo HossHans-Joerg PfleidererRalf GesslerHans-Ulrich ZietenRolf Fussgaenger
    • C12M1/34
    • A61B5/14865A61B5/14528A61B5/14532
    • The invention concerns an arrangement for determining the concentration of glucose in a tissue fluid. In the microdialysis technology used for this purpose, perfusate-containing glucose is transported in intermittent delivery pulses through a microdialysis probe inserted into the tissue fluid and dialysate obtained in this process is passed to a measuring cell to record the glucose content. In order to achieve an exact determination of glucose even with a reduced dialysis period, it is proposed that the starting content of glucose in the perfusate is adapted to the glucose content of the tissue fluid by means of a control device in accordance with a command variable derived from the measurement signals of the measuring cell. When the control deviation is negligible the momentary starting content of glucose in the perfusate can be determined as a measure for the glucose content of the tissue fluid.
    • 本发明涉及一种用于确定组织液中葡萄糖浓度的装置。 在用于此目的的微透析技术中,含有灌注液的葡萄糖通过插入组织液中的微量透析探针在间歇递送脉冲中运输,并将在该过程中获得的透析液送至测量池以记录葡萄糖含量。 为了即使在透析时间缩短的情况下也可以精确测定葡萄糖,建议根据命令变量,通过控制装置使灌注液中的葡萄糖的起始含量适应于组织液的葡萄糖含量 源自测量单元的测量信号。 当控制偏差可忽略时,灌注液中葡萄糖的瞬时起始含量可以被确定为组织液的葡萄糖含量的量度。